Concepedia

David Zuijdgeest

DZ

Statistics

Publications

13

Citations

3.3K

H-Index

13

Active since

2003

Affiliations

Janssen (Netherlands)(Current)

Johnson & Johnson (Netherlands)

Beth Israel Deaconess Medical Center

Leiden University Medical Center

Harvard University

David Zuijdgeest is an author at Janssen (Netherlands) specializing in viral vaccines, vaccinology, and infectious diseases.

ORCID

Publications per year

2003–2021

13

Publications

13

Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques

Noe B. Mercado, Roland Zahn, Frank Wegmann et al. · Nature · 2020 · 906 citations · Full text

, , +11

Highly Conserved Protective Epitopes on Influenza B Viruses

Cyrille Dreyfus, N.S. Laursen, Ted Kwaks et al. · Science · 2012 · 903 citations · Full text

, , +13

Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus Immunity

Ronald Vogels, David Zuijdgeest, Richard van Rijnsoever et al. · Journal of Virology · 2003 · 471 citations · Full text

, , +17

Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses

Rinke Bos, Lucy Rutten, Joan E. M. van der Lubbe et al. · npj Vaccines · 2020 · 373 citations · Full text

, , +17

Universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin

N.S. Laursen, Robert H. Friesen, Xueyong Zhu et al. · Science · 2018 · 233 citations

, , +17

1–5 of 13